Improved diabetes medication convenience and satisfaction in persons with type 2 diabetes after switching to insulin glargine 300 U/mL: results of the observational OPTIN-D study

OBJECTIVE: Insulin glargine 300 (Gla-300) provides less hypoglycemia risk and more flexibility in injection time. The extent to which these effects translate into improved patient-reported outcomes (PROs) is unknown, and is the subject of this observational study. RESEARCH DESIGN AND METHODS: Adults...

Descripción completa

Detalles Bibliográficos
Autores principales: Wieringa, Thomas H, de Wit, Maartje, Twisk, Jos WR, Snoek, Frank J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Emerging Technologies and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169664/
https://www.ncbi.nlm.nih.gov/pubmed/30305908
http://dx.doi.org/10.1136/bmjdrc-2018-000548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169664/
https://www.ncbi.nlm.nih.gov/pubmed/30305908
http://dx.doi.org/10.1136/bmjdrc-2018-000548

Ejemplares similares